Disclaimer
This was a promotional event organised and funded by Pierre Fabre intended for Healthcare Professionals (HCPs) practicing within Europe.
Watch here the key takeaways from this year’s European Hematology Association (EHA) symposium that focused on the Management of Post-Transplant Lymphoproliferative Disorder (PTLD) associated with Epstein-Barr Virus (EBV).
Pierre Fabre invited international experts who offered a comprehensive review of the pathogenesis of EBV+ PTLD and an update on the current strategies for managing this condition. Recent advancements in treatment, with a particular focus on EBV-specific T-cell immunotherapy and the Phase III ALLELE study, were presented to the audience.
Watch the following videos below:
- Video 1: Facing the facts in EBV+ PTLD management – Simona Sica presents the complexities of Epstein-Barr positive Post-Transplant Lymphoproliferative Disorder (EBV+ PTLD)
- Video 2: The current face of EBV+ PTLD management – Christof Scheid explores the current strategies regarding EBV+ PTLD management
- Video 3: Changing the face of EBV+ PTLD management: EBV-specific T-cell immunotherapy – Manuel Guerreiro introduces us to the pioneering field of EBV-specific T cell immunotherapy for EBV+ PTLD
- Video 4: Changing the face of EBV+ PTLD management with EBVALLO® – Manuel Guerreiro presents an overview of EBVALLO® and the ALLELE® phase III study
Read through the Symposium slides below
Faculty:
Simona Sica1
Christof Scheid2
Manuel Guerreiro3
1. Associate Professor of Vascular Surgery, Policlinico Universitario Agostino Gemelli, Rome, Italy
2. Senior Physician, Professor of Stem Cell Transplantation, University Hospital of Cologne, Cologne, Germany
3. Doctor of Haematology, La Fe University and Polytechnic Hospital, Valencia, Spain
Disclaimer continued
*The prescribing information for EBVALLO may vary depending on local approval in each country, Healthcare Professionals are recommended to consult their local prescribing information before prescribing this product.
The opinions expressed in the symposium represent the opinions of the speakers and do not necessarily represent the views of Pierre Fabre. The contents of this symposium are copyright of Pierre Fabre – Pierre Fabre 2024.
All rights reserved.
For complete information, please refer to the EBVALLO Summary of Product Characteristics.
Job code: HQ-EBV-09-24-2400002
Elaboration Date: 09/2024
